Trials / Conditions / Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
5 registered clinical trials studyying Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL NCT05370430 | PeproMene Bio, Inc. | Phase 1 |
| Unknown | γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) NCT04028440 | Institute of Hematology & Blood Diseases Hospital, China | EARLY_Phase 1 |
| Completed | MB-CART20.1 Lymphoma NCT03664635 | Miltenyi Biomedicine GmbH | Phase 1 / Phase 2 |
| Completed | Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With EZH2 Gene NCT03456726 | Eisai Co., Ltd. | Phase 2 |
| Completed | A Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma NCT03009344 | Eisai Co., Ltd. | Phase 1 |